Skip to content

CONMED CNMD Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Stryker logo
StrykerSYK
Boston Scientific logo
Boston ScientificBSX
Vericel logo
VericelVCEL
OSI Systems logo
OSI SystemsOSIS
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's deferred tax assets and other non-current assets?
CONMED (CNMD) reported deferred tax assets and other non-current assets of $151.73M in Q1 2026.
How has CONMED's deferred tax assets and other non-current assets changed year-over-year?
CONMED's deferred tax assets and other non-current assets increased by 19.4% year-over-year, from $127.09M to $151.73M.
What is the long-term trend for CONMED's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), CONMED's deferred tax assets and other non-current assets has grown at a 7.7% compound annual growth rate (CAGR), from $103.64M to $150.5M.